Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stroke
Biotech
Ventyx's CV drug rapidly reduces cardio risk biomarker
Ventyx Biosciences’ cardiovascular disease drug cut levels of a biomarker for stroke and other serious risks by almost 80% within a week.
James Waldron
Oct 23, 2025 9:45am
Stryker, Siemens Healthineers team up for stroke-treating robot
Sep 18, 2025 11:30am
Siemens Healthineers deploys its 1st mobile stroke unit at UCLA
May 30, 2025 11:10am
Imperative Care launches dual-catheter stroke aspiration system
May 9, 2025 10:00am
Bioxodes halts phase 2 stroke trial after interim review success
Apr 24, 2025 9:32am
Stroke tech developers Kandu, Neurolutions to combine
Apr 8, 2025 2:00pm
